CNBC's Jim Cramer on Tuesday said it may be too soon to tell how GLP-1 diabetes and weight loss drugs will change companies, especially ones that sell junk food.on Tuesday said it may be too soon to tell how GLP-1 diabetes and weight loss drugs will affect the stock of companies like
Walmart said last week it is seeing a"slight change" in food-shopping habits, some of which may be due to customers buying less while using appetite-suppressing medications like diabetes drugs Mounjaro or Wegovy,
این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:
ایران آخرین اخبار, ایران سرفصلها
Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.
Jim Cramer's top 10 things to watch in the stock market MondayThe Dow, S&P 500 and Nasdaq were lower Monday after Hamas conducted a surprise attack on Israel.
منبع: CNBC - 🏆 12. / 72 ادامه مطلب »
Jim Cramer's top 10 things to watch in the stock market TuesdayWall Street stabilizes: The Dow, the S&P 500 and the Nasdaq little changed early Tuesday.
منبع: CNBC - 🏆 12. / 72 ادامه مطلب »
Jim Cramer explains why the Israel-Hamas war may not steer Monday's market actionCNBC’s Jim Cramer suggested the deadly conflict between Israel and Hamas may not be the driving force in Monday’s market action.
منبع: NBCDFW - 🏆 288. / 63 ادامه مطلب »
Jim Cramer sees a bull market in cybersecurityCNBC’s Jim Cramer said demand for cybersecurity is high, indicating a potential bull market for the sector.
منبع: nbcchicago - 🏆 545. / 51 ادامه مطلب »